Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · IEX Real-Time Price · USD
283.45
-4.95 (-1.72%)
Jun 13, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.04 billion as of July 2, 2024. Its market cap has decreased by -25.08% in one year.
Market Cap
8.04B
Enterprise Value
n/a
1-Year Change
-25.08%
Ranking
Category
Stock Price
$283.45
Market Cap Chart
Since July 5, 2019, Bio-Rad Laboratories's market cap has decreased from $9.34B to $8.04B, a decrease of -13.95%. That is a compound annual growth rate of -2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 7.63B | -17.93% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 57.32% |
| Dec 31, 2019 | 11.05B | 18.28% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Encompass Health | 8.62B |
| Henry Schein | 8.40B |
| Vaxcyte | 8.27B |
| Chemed | 8.20B |
| Legend Biotech | 8.16B |
| Exact Sciences | 7.97B |
| Roivant Sciences | 7.80B |
| Ascendis Pharma | 7.71B |